| Windsor Cypress Gardens | |
| 9025 Colorado Avenue, Riverside, California 92503 | |
| (951) 688-3643 | |
| Name | Windsor Cypress Gardens |
|---|---|
| Location | 9025 Colorado Avenue, Riverside, California |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 71.08% |
| Medicare ID (CCN) | 056315 |
| Legal Business Name | Windsor Cypress Gardens Healthcare, Llc |
| Ownership Type | For Profit - Limited Liability Company |
| NPI Number | 1366643603 |
| Organization Name | MUTUAL CARE MANAGEMENT, INC. |
| Doing Business As | SAME |
| Address | 9025 Colorado Ave, Riverside, CA 92503 |
| Phone Number | 951-688-3636 |
News Archive
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Ortho Clinical Diagnostics' VITROS XT MicroSlides, featuring new, multi-test technology that allows labs to run two tests simultaneously on one MicroSlide, have been cleared for market by the U.S. Food and Drug Administration.
ValueRich, Inc. announced today that the company has commenced litigation against China Pharmaceuticals, a publicly traded company under the symbol for breach of contract and other related claims. ValueRich alleges ownership of 20% of the outstanding shares of China Pharmaceuticals "pursuant to a May 2009 Consulting Agreement between ValueRich and Xian Pharmaceuticals, Ltd, the Chinese-based operating company for China Pharmaceuticals."
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
› Verified 4 days ago
| NPI Number | 1770884868 |
| Organization Name | 9025 COLORADO AVENUE LLC |
| Doing Business As | CYPRESS GARDENS CARE CENTER |
| Address | 9025 Colorado Ave, Riverside, CA 92503 |
| Phone Number | 951-688-3636 |
News Archive
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Ortho Clinical Diagnostics' VITROS XT MicroSlides, featuring new, multi-test technology that allows labs to run two tests simultaneously on one MicroSlide, have been cleared for market by the U.S. Food and Drug Administration.
ValueRich, Inc. announced today that the company has commenced litigation against China Pharmaceuticals, a publicly traded company under the symbol for breach of contract and other related claims. ValueRich alleges ownership of 20% of the outstanding shares of China Pharmaceuticals "pursuant to a May 2009 Consulting Agreement between ValueRich and Xian Pharmaceuticals, Ltd, the Chinese-based operating company for China Pharmaceuticals."
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
› Verified 4 days ago
| NPI Number | 1831748714 |
| Organization Name | WINDSOR CYPRESS GARDENS HEALTHCARE, LLC |
| Address | 9025 Colorado Ave, Riverside, CA 92503 |
| Phone Number | 951-688-3636 |
News Archive
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Ortho Clinical Diagnostics' VITROS XT MicroSlides, featuring new, multi-test technology that allows labs to run two tests simultaneously on one MicroSlide, have been cleared for market by the U.S. Food and Drug Administration.
ValueRich, Inc. announced today that the company has commenced litigation against China Pharmaceuticals, a publicly traded company under the symbol for breach of contract and other related claims. ValueRich alleges ownership of 20% of the outstanding shares of China Pharmaceuticals "pursuant to a May 2009 Consulting Agreement between ValueRich and Xian Pharmaceuticals, Ltd, the Chinese-based operating company for China Pharmaceuticals."
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Ortho Clinical Diagnostics' VITROS XT MicroSlides, featuring new, multi-test technology that allows labs to run two tests simultaneously on one MicroSlide, have been cleared for market by the U.S. Food and Drug Administration.
ValueRich, Inc. announced today that the company has commenced litigation against China Pharmaceuticals, a publicly traded company under the symbol for breach of contract and other related claims. ValueRich alleges ownership of 20% of the outstanding shares of China Pharmaceuticals "pursuant to a May 2009 Consulting Agreement between ValueRich and Xian Pharmaceuticals, Ltd, the Chinese-based operating company for China Pharmaceuticals."
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 2.65 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 12.38 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 30 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.87 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.91 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 1.15 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 2.57 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 97.84 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 6.64 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 14.37 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 14.03 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 98.9 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 84.27 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 97.36 | 82.93 |
News Archive
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc, with Pfizer Inc. and Shionogi Limited as shareholders, is pleased to announce that eligible people living with Human Immunodeficiency Virus (HIV) in England and Wales will soon have routine access to Vocabria (cabotegravir long-acting injection) developed by ViiV Healthcare in combination with Rekambys (rilpivirine long-acting injection), developed by Janssen Sciences Ireland UC (Janssen), one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Ortho Clinical Diagnostics' VITROS XT MicroSlides, featuring new, multi-test technology that allows labs to run two tests simultaneously on one MicroSlide, have been cleared for market by the U.S. Food and Drug Administration.
ValueRich, Inc. announced today that the company has commenced litigation against China Pharmaceuticals, a publicly traded company under the symbol for breach of contract and other related claims. ValueRich alleges ownership of 20% of the outstanding shares of China Pharmaceuticals "pursuant to a May 2009 Consulting Agreement between ValueRich and Xian Pharmaceuticals, Ltd, the Chinese-based operating company for China Pharmaceuticals."
Misonix, Inc. has announced today that its majority-owned Sonora Medical Systems, Inc. subsidiary has received the first of three patents filed for its FirstCall 2000 ultrasound probe-testing device. The patent enforces the FirstCall device's unique process for testing ultrasound probes on site without requiring the ultrasonic system to be in operation.
› Verified 4 days ago
Alta Vista Healthcare & Wellness Centre Location: 9020 Garfield Street, Riverside, California 92503 Phone: (951) 688-8200 | |
Vista Pacifica Convalescent Hospital Location: 3662 Pacific Avenue, Riverside, California 92509 Phone: (951) 682-4833 | |
Community Care And Rehabilitation Center Location: 4070 Jurupa Avenue, Riverside, California 92506 Phone: (951) 680-6500 | |
Magnolia Rehabilitation & Nursing Center Location: 8133 Magnolia Avenue, Riverside, California 92504 Phone: (951) 688-4321 | |
Jurupa Hills Post Acute Location: 6401 33rd Street., Riverside, California 92509 Phone: (951) 681-2200 |